Abstract
In this review we report recent findings on the physiological role of the five known muscarinic acetylcholine receptors (mAChRs) as shown by gene targeting technology. Using knockout mice for each mAChRs subtype, the role of mAChRs subtypes in a number of physiological functions was confirmed and new activities were discovered. The M1 mAChRs modulate neurotransmitter signaling in cortex and hippocampus. The M3 mAChRs are involved in exocrine gland secretion, smooth muscle contractility, pupil dilation, food intake, and weight gain. The role of the M5 mAChRs involves modulation of central dopamine function and the tone of cerebral blood vessels. mAChRs of the M2 subtype mediate muscarinic agonist-induced bradycardia, tremor, hypothermia, and autoinhibition of release in several brain regions. M4 mAChRs modulate dopamine activity in motor tracts and act as inhibitory autoreceptors in striatum. Thus, as elucidated by gene targeting technology, mAChRs have widespread and manifold functions in the periphery and brain.
Similar content being viewed by others
REFERENCES
Gomeza, J., Shannon, H. E., Kostenis, E., Felder, C., Zhang, L., Brodkin, J., Grinberg, A., Sheng, H., and Wess, J. 1999a. Pronounced pharmacological deficits in M2 muscarinic acetylcholine receptor knockout mice. Proc. Natl. Acad. Sci. USA 96:1692–1697.
Bymaster, F. P., Shannon, H. E., Rasmussen, K., DeLapp, N. W., Ward, J. S., Calligaro, D. O., Mitch, C. H., Whitesitt, C., Ludvigsen, T. S., Sheardown, M., Swedberg, M., Rasmussen, T., Olesen, P. H., Jeppesen, L., Sauerberg, P., and Fink-Jensen, A. 1999. Potential role of muscarinic receptors in schizophrenia. Life Sci. 64:527–534.
Felder, C. C., Bymaster, F. P., Ward, J., and DeLapp, N. 2000. Therapeutic opportunities for muscarinic receptors in the central nervous system. J. Med. Chem. 43:4333–4353.
Eglen, R. M., Choppin, A., Dillon, M. P., and Hegde, S. 1999. Muscarinic receptor ligands and their therapeutic potential. Curr. Opin. Chem. Biol. 3:426–432.
Cutler, N. R. and Sramek, J. J. 1995. Muscarinic M1-receptor agonists: Potential in the treatment of Alzheimer's disease. CNS Drugs 3:467–481.
Gomeza, J., Zhang, L., Kostenis, E., Felder, C., Bymaster, F., Brodkin, J., Shannon, H., Xia, B., Deng, C.-X., and Wess, J. 1999b. Enhancement of D1 dopamine receptor-mediated locomotor stimulation in M4 muscarinic acetylcholine receptor knockout mice. Proc. Natl. Acad. USA 96:10483–10488.
Miyakawa, T., Yamada, M., Duttaroy, A., and Wess, J. 2001. Hyperactivity and intact hippocampus-dependent learning in mice lacking the m1 muscarinic acetylcholine receptor. J. Neuorsci. 21:5239–5250.
Yamada, M., Miyakawa, T., Duttaroy, A., Yamanaka, A., Moriguchi, T., Makita, R., Ogawa, M., Chou, C. J., Xia, B., Crawley, J. N., Felder, C. C., Den, C.-X., and Wess, J. 2001a. Mice lacking the M3 muscarinic acetylcholine receptor are hypophagic and lean. Nature 410:207–212.
Yamada, M., Lamping, K. G., Duttaroy, A., Zhang, W., Cui, Y., Bymaster, F. P., McKinzie, D. L., Felder, C. C., Deng, C.-X., Faraci, F. M., and Wess, J. 2001b. Cholinergic dilation of cerebral blood vessels is abolished in M5 muscarinic acetylcholine receptor knockout mice. Proc. Natl. Acad. Sci. USA 98:14096–14101.
Levey, A. I. 1993. Immunological localization of m1-m5 muscarinic acetylcholine receptors in peripheral tissues and brain. Life Sci. 52:441–448.
Caulfield, M. P. and Birdsall, N. J. M. 1998. International Union of Pharmacology: XVII. Classification of muscarinic acetylcholine receptors. Pharmacol. Rev. 50 279-290.
Roszkowski, A. 1961. An unusual type of sympathetic ganglionic stimulant. J. Pharmacol. Exp. Ther. 132:156–170.
Hardouin, S. N., Richmond, K. N., Zimmerman, A., Hamilton, S. E., Feigl, E. O., and Nathanson, N. M. 2002. Altered cardiovascular responses in mice lacking the M1 muscarinic acetylcholine receptor. J. Pharmacol. Exp. Ther. 301:129–137.
Hamilton, S. E., Loose, M. D., Qi, M., Levey, A. I., Hille, B., McKnight, G. S., Idzerda, R. L., and Nathanson, N. M. 1997. Disruption of the m1 receptor gene ablates muscarinic receptor-dependent M current regulation and seizure activity in mice. Proc. Natl. Acad. Sci. USA 94:13311–13316.
Bymaster, F. P., Carter, P. A., Yamada M., Gomeza, J., Wess, J., Hamilton, S. E., Nathanson, N. M., McKinzie, D., and Felder, C. C. 2002. Role of specific muscarinic receptor subtypes in cholinergic parasympathomimetic responses, in vivo phosphoinositide hydrolysis, and pilocarpine-induced seizure activity. Eur. J. Neuroscience, Submitted.
Felder, C. C., Porter, A. C., Skillman, T. L., Zhang, L., Bymaster, F. P., Nathanson, N. M., Hamilton, S. E., Gomeza, J., Wess, J., and McKinzie, D. L. 2001. Elucidating the role of muscarinic receptors in psychosis. Life Sci. 68:2605–2613.
Porter, A. C., Bymaster, F. P., DeLapp, N. W., Yamada, M., Wess, J., Hamilton, S. E., Nathanson, N. M., and Felder, C. C. 2002. M1 muscarinic receptor signaling in mouse hippocampus and cortex. Brain Res. 944:82–89.
Hamilton, S. E. and Nathanson, N. M. 2001. The M1 receptor is required for muscarinic activation of mitogen-activated protein (MAP) kinase in murine cerebral cortical neurons. J. Biol. Chem. 276:15850–15853.
Berkeley, J. L., Gomeza, J., Wess, J., Hamilton, S. E., Nathanson, N. M., and Levey, A. I. 2001. M1 Muscarinic acetylcholine receptors activate extracellular signal-regulated kinase in CA1 pyramidal neurons in mouse hippocampal slices. Mol. Cell Neurosci. 18:512–524.
Sarter, M. and Bruno, J. P. 1997. Cognitive functions of cortical acetylcholine: Toward a unifying hypothesis. Brain Res. Brain Res. Rev. 23:28–46.
Gerber, D. J., Sotnikova, T. D., Gainetdinov, R. R., Huang, S. H. and Caron, M. G. 2001. Hyperactivity, elevated dopaminergic transmission, and response to amphetamine in M1 muscarinic acetylcholine receptor-deficient mice. Proc. Natl. Acad. Sci. USA 98:15312–15317.
Greene, S. J., Felder, C. C., Hamilton, S. E., Nathanson, N. M., and Gannon, K. S. 2001. Analyses of spatial learning and activity in muscarinic M1 receptor knockout mice: Evidence for a cognitive deficit. Soc. Neurosci. Abstrs. 27:prog #79.12.
Anagnostaras, S. G., Murphy, G. G., Sage J. R., Hamilton, S. E., Nathanson, N. M., and Silva, A. J. 2000. Learning and memory in acetylcholine muscarinic M1 receptor knockout mice. Soc. Neurosci. Abstr. 26:1509.
Caulfield, M. P. 1993. Muscrinic receptors characterization, coupling and function. Pharmacol. Ther. 58 319–379.
Matsui, M., Motomura, D., Karasawa, H., Fujikawa, T., Jiang, J., Komiya, Y., Takahashi, S.-I., and Taketo, M. M. 2000. Multiple functional defects in peripheral autonomic organs in mice lacking muscarinic acetylcholine receptor gene for the M3 subtype. Proc. Natl. Acad. Sci. USA 97:9579–9584.
Stengel, P. W., Yamada, M., Wess, J., and Cohen, M. L. 2002. M3 receptor knockout mice: Muscarinic receptor function in atria, stomach fundus, urinary bladder and trachea in vitro. Am. J. Physiol. 282:R1443–R1449.
Gil, D. W., Krauss, H. A., Bogardus, A. M., and WoldeMussie, E. 1997. Muscarinic receptor subtypes in human iris-ciliary body measured by immunoprecipitation. Invest. Ophthalmol. Vis. Sci. 38:1434–1442.
Ishizaka, N., Noda, M., Yokoyama, S., Kawasaki, K., Yamamoto, M., and Higashida, H. 1998. Muscarinic acetylcholine receptor subtypes in the human iris. Brain Res. 787:344–347.
Phillips, J. K., Vidovic, M., and Hill, C. E. 1997. Variation in mRNA expression of alpha-adrenergic, neurokinin and muscarinic receptors amongst four arteries of the rat. J. Auton. Nerv. Syst. 62:85–93.
Elhusseiny, A., Cohen, Z., Olivier, A., Stanimirovic, D. B., and Hamel, E. 1999. Functional acetylcholine muscarinic receptor subtypes in human brain microcirculation: identification and cellular localization. J. Cereb. Blood Flow Metab. 19:794–802.
Weiner, D. M., Levey, A. I., and Brann, M. R. 1990. Expression of muscarinic acetylcholine and dopamine receptor mRNAs in rat basal ganglia. Proc. Natl. Acad. Sci. USA 87:7050–7054.
Yeomans, J., Forster, G., and Blaha, C. 2001. M5 muscarinic receptors are needed for slow activation of dopamine neurons and for rewarding brain stimulation. Life Sci. 68:2449–2456.
Stengel, P. W., Gomeza, J., Wess, J., and Cohen, M. L. 2000. M2 and M4 receptor knockout mice: muscarinic receptor function in cardiac and smooth muscle in vitro. J. Pharmacol. Exp. Ther. 292:877–885.
Marchi, M. and Raiteri, M. 1985. On the presence in the cerebral cortex of muscarinic receptor subtypes which differ in neuronal localization, function and pharmacological properties. J. Pharmacol. Exp. Ther. 235:230–233.
Damsma, G., de Boer, P., Westerink, B. H., and Fibiger, H. C. 1990. Dopaminergic regulation of striatal cholinergic interneurons: An in vivo microdialysis study. Naunyn Schmiedebergs Arch. Pharmacol. 342:523–527.
Zhang, W., Basile, A. S., Gomeza, J., Volpicelli, L. A., Levey, A. I., and Wess, J. 2002. Characterization of central inhibitory muscarinic autoreceptors by the use of muscarinic acetylcholine receptor knock-out mice. J. Neurosci. 22:1709–1717.
Swedberg, M. D., Sheardown, M. J., Sauerberg, P., Olesen, P. H., Suzdak, P. D., Hansen, K. T., Bymaster, F. P., Ward, J. S., Mitch, C. H., Calligaro, D. O., Delapp, N. W., and Shannon, H. E. 1997. Butylthio[2.2.2] (NNC 11–1053/LY297802): An orally active muscarinic agonist analgesic. J. Pharmacol. Exp. Ther. 281:876–883.
Hemrick-Luecke, S. K., Felder, C. C., Evans, D. E., Wess, J., and Bymaster, F. P. 2000. Effect of BuTAC on the elevation of serum corticosterone concentrations in M2 and M4 muscarinic acetylcholine receptor knockout mice. Soc. Neurosci. Abstr. 26:1644.
Hemrick-Luecke, S. K., Bymaster, F. P., Evans, D. C., Wess, J., and Felder, C. C. 2002. Muscarinic agonist-mediated increases in serum corticosterone levels are abolished in m2 muscarinic acetylcholine receptor knockout mice. J. Pharmacol. Exp. Ther. 303:99-103.
Kilbinger, H., Von Bardeleben, R. S., Siefken, H., and Wolf, D. 1995. Prejunctional muscarinic receptors regulating neurotransmitter release in airways. Life Sci. 56:981–988.
Bernard, V., Normand, E., and Bloch, B. 1992. Phenotypical characterization of the rat striatal neurons expressing muscarinic receptor genes. J. Neurosci. 12:3591–3600.
Duttaroy, A., Gomeza, J., Gan, J.-W., Basile, A. S., Harman, W. D., Smith, P. L., Felder, C. C., and Wess, J. 2000. Analysis of muscarinic agonist-induced analgesia by the use of receptor knockout mice. Soc. Neurosci. Abstr. 26:1644.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bymaster, F.P., McKinzie, D.L., Felder, C.C. et al. Use of M1–M5 Muscarinic Receptor Knockout Mice as Novel Tools to Delineate the Physiological Roles of the Muscarinic Cholinergic System. Neurochem Res 28, 437–442 (2003). https://doi.org/10.1023/A:1022844517200
Issue Date:
DOI: https://doi.org/10.1023/A:1022844517200